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630Objectives: This is a report to update our experience with repairs of the ascending and transverse arch, with an
emphasis on the protective measures, including retrograde cerebral perfusion and blood flow and neurologic
monitoring.
Methods: Retrospective data were collected from January 1991 to February 2010, and analysis was conducted
on 1193 patients who had aneurysms involving the ascending aorta and arch.
Results: The 30-day mortality rate was 9.3%, but with a normal glomerular filtration rate, the mortality rate was
3%. In univariate analysis of the risk factors for death, the factors were advancing age of greater than 72 years
(mortality, 14.8%; P¼ .002), the presence of coronary artery disease (mortality, 13.5%; P¼ .02), aortic pathol-
ogy of acute dissection (mortality, 13.9%; P ¼ .004), the emergency nature of the operation (mortality, 16.1%;
P ¼ .0001), and renal function in the lowest 3 quartiles of glomerular filtration rate (mortality, 6.9%, 10%, and
18.3%; P¼ .03, .0005, and .0001, respectively, with decreasing glomerular filtration rate). The highest quartile
for pump time (>179 minutes) had a mortality rate of 18.1% (P ¼ .0001). The overall stroke rate was 3%. In
univariate analysis of risk factors for stroke, the stroke rate was 2.8%with and 4.2%without retrograde cerebral
perfusion (P ¼ .30), but when circulatory arrest time exceeded 40 minutes, the stroke rate was 1.7% with and
30% without retrograde cerebral perfusion (P ¼ .002). Risk factors included age greater than 62 years (stroke
rate, 4%; P ¼ .04), hypertension (stroke rate, 3.7%; P ¼ .03), emergency operations (stroke rate, 4.9%;
P¼ .04), and glomerular filtration rate of less than 56 (stroke rate, 4.3%; P¼ .05). In multiple logistic regression
for risk factors for stroke, age was associated with an odds ratio of 1.04 (P ¼ .008), and emergency conditions
had an odds ratio of 2.17 (P ¼ .03).
Conclusions: Retrograde cerebral perfusion was associated with a trend toward a reduced incidence of hospital
mortality and, in patients receiving prolonged hypothermic circulatory arrest, a reduced incidence of stroke.
(J Thorac Cardiovasc Surg 2011;142:630-3)The optimal strategy for cerebral protection during ascend-
ing and transverse aortic arch repair remains undetermined.
Since the study by Griepp and colleagues1 reporting the ini-
tial use of profound hypothermic circulatory arrest for
transverse arch repairs, 2 cerebral protective approaches
have emerged: retrograde cerebral perfusion (RCP) and an-
tegrade cerebral perfusion (ACP). Ueda and associates2 first
reported RCP used in conjunction with profound hypother-
mic circulatory arrest during ascending and transverse arch
repairs. Reported advantages of RCP were flushing out of
atheromatous debris, uniform cerebral cooling, ease of
use, and potential nutritive support.2-4 ACP, which is used
by the majority of groups, claimed improved neurologic
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The Journal of Thoracic and Cardiovascular Surging ACP would allow for a longer duration of cerebral pro-
tection because of the improved ability to provide direct
nutritive flow and oxygen to cerebral tissues.6-12 The
difficulty in assessing the efficacy of these approaches,
however, has been related to the varying cannulation
strategies, differing monitoring approaches, and use of
combinations of techniques.
We adopted the use of RCP as the main method of cere-
bral protection in 1993 following animal and clinical re-
sults.13,14 Since that time, we have reported good results
regarding neurologic outcome during ascending and arch
repairs.3 This report updates our experience with RCP
with repairs of the ascending and transverse arch aorta.
MATERIALS AND METHODS
Patients
Based on data collection between January 1991 and February 2010, our
group repaired 1290 aneurysms involving the ascending aorta and arch.
Complete datawere available on 1193 cases, and these comprised our study
sample. The median age of the patient was 65 years and ranged from ages
16 to 93 years. The cases included 754 (63%) male and 439 (37%) female
subjects. The mortality rate of the study sample (112/1193 [9.3%]) was not
different from that of the excluded population (15/97 [15.4%]), indicating
that the sample analyzed is representative of the census (P ¼ .07).
Stroke was defined as any gross focal neurologic brain injury, either
temporary or permanent, as identified on neurologic examination by a neu-
rology consultant and confirmed with computed tomographic scanning or
magnetic resonance imaging. Emergency/urgent cases included rupture,ery c September 2011
TABLE 1. Univariate analysis of mortality risks
Variable
Total
(%)
Deaths
(%) OR 95% CI
P
value
Total 1193 (100) 112 (9.3)
Age
55 298 (25.0) 20 (6.7)
56–64 301 (25.2) 14 (4.7) 0.68 0.34–1.37 .28
65–71 277 (23.2) 31 (11.2) 1.75 0.98–2.86 .06
 72 317 (26.6) 47 (14.8) 2.21 1.34–3.64 .002
Female sex 439 (36.8) 43 (9.8) 1.08 0.72–1.61 .71
Male sex 754 (63.2) 69 (9.2) 1
HTN 872 (73.1) 77 (8.8) 0.79 0.52–1.21 .27
No HTN 321 (26.9) 35 (10.9) 1
COPD 248 (20.8) 24 (9.7) 1.04 0.65–1.68 .87
No COPD 945 (79.2) 88 (9.3) 1
CAD 237 (19.9) 32 (13.5) 1.71 1.01–2.65 .02
No CAD 956 (80.1) 80 (8.4) 1
Pathology
Acute
dissection
296 (24.8) 41 (13.9) 1.75 1.19–2.56 .004
Chronic
dissection
215 (18.0) 17 (7.9) 1.00 0.59–1.69 1.0
Aneurysm 682 (57.2) 54 (7.9) 1
Emergency 285 (23.9) 46 (16.1) 2.46 1.64–3.67 .0001
Elective 908 (76.1) 66 (7.3)
GFR
56 279 (23.4) 51 (18.3) 6.09 3.06–2.14 .0001
57–78 310 (25.9) 31 (10.0) 3.33 1.62–6.88 .0005
79–106 304 (25.5) 21 (6.9) 2.30 1.07–4.95 .03
107 300 (25.2) 9 (3.0) 1
Pump time (min)
Not reported 14
119 299 (25.3) 18 (6.0) 1
120–146 293 (24.9) 16 (5.5) 0.91 0.47–1.74 .76
147–178 294 (24.9) 21 (7.1) 1.19 0.65–2.18 .58
179 293 (24.9) 53 (18.1) 3.01 1.81–5.00 .0001
RCP 1002 (84.0) 87 (8.6) 0.63 0.39–1.01 .055
No RCP 191 (16.0) 25 (13.1)
OR, Odds ratio; CI, confidence interval; HTN, hypertension; COPD, chronic obstruc-
tive pulmonary disease; CAD, coronary artery disease; GFR, glomerular filtration
rate; RCP, retrograde cerebral perfusion.
Abbreviations and Acronyms
ACP ¼ antegrade cerebral perfusion
GFR ¼ glomerular filtration rate
RCP ¼ retrograde cerebral perfusion
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Dacute dissection, and symptomatic aneurysms related to infection or
fistulas.
Technique
Our methods for repairing ascending and arch aneurysms have been de-
scribed previously.15-17 We use cardiopulmonary bypass, profound
hypothermia, circulatory arrest, and RCP. We monitor cerebral function
with infrared spectroscopy or power mode transcranial Doppler
scanning to confirm the presence of cerebral circulation. A 10-lead
electroencephalogram is used to monitor brain function. The patient is
cooled until the electroencephalogram is isoelectric. This usually
coincides with a nasopharyngeal temperature of between 20C and 15C.
Once that temperature is achieved and the pupils are fixed and dilated,
cardiopulmonary bypass is discontinued and circulatory arrest is
established. RCP through the superior vena caval cannula is initiated.
The flow rate varies based on the information obtained from the power
mode transcranial Doppler ultrasound and bilateral infrared
spectroscopic analysis. This is to demonstrate the adequacy of RCP, as
determined by the presence of reversed flow in the middle cerebral
artery. In the past, we found that the high opening pressure required to
maintain the flow is usually less than 500 mL/min. We were able to
maintain the pressure of the superior vena cava at less than 25 mm Hg.
The arch is generally repaired by resecting the 2 lateral walls and the
lesser curvature and replacing it with a Dacron graft. If there is an aneurysm
present in the descending or thoracoabdominal aneurysm, then we use the
standard elephant trunk technique with a collared graft.18 The graft is in-
serted into the descending thoracic aorta at about 10 to 15 cm, and the collar
ring is sewn to the thoracic aorta distal to the left subclavian artery. A side
hole is made in the graft for reattachment of the cerebral and subclavian
vessels. Bleeding points are secured, cerebral perfusion is restarted, and
systemic circulation is allowed to flow through the sidearm, which is pre-
manufactured and attached to the graft. The patient’s head is raised, and the
body is rewarmed.
Then we turn our attention to the tubular portion of the ascending aorta,
which we excise, and suture our graft above the supracoronary ascending
aorta. In cases in which the aortic root is dilated, the root is replaced
with a composite valve graft prosthesis. In the event of acute dissection,
we reconstruct the aortic root and resuspend the valve and reattach the
reconstructed supracoronary ascending aorta to the graft.
Once the distal anastomosis is accomplished, we rewarm the patient’s
heart to a myocardial septal temperature of 30C, and then we release
the ascending aortic clamp and restore the flow to the coronary circulation.
Once the patient’s core body temperature is 36C and they are able to main-
tain good systemic blood pressure and sinus rhythm, they are weaned from
cardiopulmonary bypass.
The Committee for the Protection of Human Subjects at the University
of Texas Medical School at Houston approved review of the data collected
for this study. Consent was waived for the retrospective analysis.
RESULTS
The 30-day mortality rate was 9.3%, or 112 of 1193, but
with a normal glomerular filtration rate (GFR), the mortal-
ity rate was 3%. The hospital mortality was 9.1% (109/
1193). Table 1 shows the univariate analysis of the riskThe Journal of Thoracic and Cafactors for death, which were advancing age of greater
than 72 years (mortality, 14.8%; P ¼ .002), the presence
of coronary artery disease (mortality, 13.5%; P¼ .02), aor-
tic pathology of acute dissection (mortality, 13.9%;
P¼ .004), the emergency nature of the operation (mortality,
16.1%; P¼ .0001), and renal function in the lowest 3 quar-
tiles of GFR (mortality, 6.9%, 10%, and 18.3%; P ¼ .03,
.0005, and .0001, respectively, with decreasing GFR). The
highest pump time range (>179 minutes) had a mortality
rate of 18.1% (P¼ .0001). The overall stroke rate was 3%.
Table 2 shows the univariate analysis of risk factors for
stroke. For all cases, the stroke rate was 2.8% with and
4.2% without RCP (P ¼ .30), but for cases in which circu-
latory arrest time exceeded 40 minutes, the stroke rate was
1.7% with and 30% without RCP (P ¼ .002). Risk factorsrdiovascular Surgery c Volume 142, Number 3 631
TABLE 2. Univariate analysis of risk factors for stroke
Variable
Total
(%)
Strokes
(%) OR 95% CI
P
value
Total 1193 (100) 36 (3.0)
Age (y)
50 298 (25.0) 3 (1.0) 1
51–62 301 (25.2) 10 (3.3) 3.38 0.8–19.26 .09
63–71 277 (23.2) 11 (4.0) 4.07 1.06–22.89 .04
72 317 (26.6) 12 (3.8) 3.87 1.03–21.54 .04
Female sex 439 (36.8) 14 (3.2) 1.09 0.55–2.17 .86
Male sex 754 (63.2) 22 (2.9) 1
HTN 872 (73.1) 32 (3.7) 3.02 1.06–8.61 .03
No HTN 321 (26.9) 4 (1.3) 1
COPD 248 (20.8) 11 (4.4) 1.71 0.83–3.52 .14
No COPD 945 (79.2) 25 (2.7) 1
CAD 237 (19.9) 8 (3.4) 1.16 0.52–2.57 .67
No CAD 956 (80.1) 28 (2.9) 1
Pathology
Acute dissection 296 (24.8) 11 (3.7) 1.21 0.52–2.68 .74
Chronic dissection 215 (18.0) 4 (1.9) 0.60 0.15–1.80 .49
Aneurysm 682 (57.2) 21 (3.1) 1
Emergency 285 (23.9) 14 (4.9) 2.08 1.05–4.12 .04
Elective 908 (76.1) 22 (2.4) 1
GFR
56 279 (23.4) 12 (4.3) 3.33 1.06–10.44 .05
57–78 310 (25.9) 12 (3.9) 2.98 0.95–9.34 .08
79–106 304 (25.5) 8 (2.6) 2.00 0.60–6.70 .39
107 300 (25.2) 4 (1.3) 1
Pump time (min)
Not reported 14
119 299 (25.3) 7 (2.3) 1
120–146 293 (24.9) 12 (4.1) 1.78 0.69–4.59 .24
147–178 294 (24.9) 6 (2.0) 0.87 0.29–2.62 .80
179 293 (24.9) 11 (3.8) 1.63 0.62–4.26 .44
RCP 1002 (84.0) 28 (2.8) 0.66 0.29–1.47 .30
No RCP 191 (16.0) 8 (4.2)
For circulatory
arrest times
>40 min
RCP 233 (95.9) 4 (1.7) 0.04 0.01–0.22 .002
No RCP 10 (4.1) 3 (30.0)
OR, Odds ratio; CI, confidence interval; HTN, hypertension; COPD, chronic obstruc-
tive pulmonary disease; CAD, coronary artery disease; GFR, glomerular filtration
rate; RCP, retrograde cerebral perfusion.
TABLE 3. Risk factors for stroke (multiple logistic regression)
Variable
Parameter
Estimate Odds Ratio 95% CI
P
value
Intercept 5.9407
Age 0.0354 1.04 1.01–1.06 .008
Emergency status 0.7749 2.17 1.09–4.32 .03
CI, Confidence interval.
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P ¼ .04), hypertension (stroke rate, 3.7%; P ¼ .03), emer-
gency operations (stroke rate, 4.9%; P ¼ .04), and GFR of
less than 56 (stroke rate, 4.3%; P ¼ .05).
Table 3 shows the multiple logistic regression results in
terms of risk factors for stroke. Age was associated with
an odds ratio of 1.04 (P ¼ .008), and emergency conditions
had an odds ratio of 2.17 (P ¼ .03).
DISCUSSION
Since the 1970s, the main method for repair of complex
ascending and arch aneurysms has been with the use of632 The Journal of Thoracic and Cardiovascular Surgprofound hypothermia and circulatory arrest. In the
1980s, RCP was used as an adjunct to extend the patient’s
tolerance of cerebral ischemic time. RCP remained contro-
versial because there was no randomized trial to prove its
efficacy. In this study we found that RCP protects patients
from stroke. Incidentally, we also observed a trend in de-
creasing mortality with use of RCP (P ¼ .055). Because
the causes of death were not necessarily related to stroke,
the relationship of mortality and RCP remained unclear.
In univariate analysis age was a risk factor for stroke if
the patient’s age was greater than 70 years. The presence
of hypertension and the emergency nature of the operation
were also significant risks. Pump time was not a significant
factor in either univariate or multivariate analysis. At a cir-
culatory arrest time of greater than 40 minutes, we found
great benefit in the use of RCP. In multiple logistic regres-
sion, as described in Table 3, older age and emergency sta-
tus were more likely to result in the occurrence of stroke.
In the mid-1980s and 1990s, several methods were de-
vised to extend the tolerance of the brain to ischemia and
thus to minimize the risk of stroke. One method is to use
ACP, either through axillary cannulation or with direct bal-
loon catheter insertion into the left or right common carotid
artery, perfusing in an antegrade fashion. This required
monitoring of the right radial artery, keeping the cerebral
perfusion pressure at greater than 40 to 60 mm Hg and
the flow rate at about 10 mL $ mg1 $ min1. We used this
integrated approach of antegrade and retrograde perfusion
and found that there was no difference in pressure using
antegrade or retrograde perfusion.19 We have continued to
use cardiopulmonary bypass, profound hypothermia, and
circulatory arrest along with RCP.
With the advent of endovascular treatment of various tho-
racic aneurysms, a hybrid approach was introduced. This
uses the ascending aorta for cardiopulmonary bypass and
places the ascending aorta from the graft to the brachioce-
phalic arteries. Alternatively, it uses the proximal portion
of the ascending aorta as a graft site and branches into the
brachiocephalic artery, followed by insertion of the stent
graft in the ascending arch and descending thoracic aorta.
The incidence of stroke and mortality has been high in sev-
eral studies; the potential benefits might be greater in el-
derly, very high-risk patients, with less benefit for younger
low-risk patients compared with open approaches.20 There
are others who advocate moderate hypothermia in patients
with arch aneurysms with good results.21 We think that theery c September 2011
Safi et al Acquired Cardiovascular Diseasepatient should be protected with the use of profound hypo-
thermia with cardiopulmonary bypass to minimize potential
neurologic damage.
In summary, we used RCP as described in our technique.
We used transcranial Doppler scanning to direct the retro-
grade perfusion, as well as cerebral oximetry to demonstrate
RCP in the cerebral vessels. This has been shown to im-
prove the stroke rate, as well as the mortality rate. Some
have stated that RCP is detrimental for increased cerebral
edema and hypothermia.6 In this study RCP had superior re-
sults when adjusting the superior vena caval pressure to less
than 25 mm Hg. The rate was 1.7% compared with 4.1%
without RCP (P ¼ .002), despite a prolonged cerebral
ischemia of greater than 40 minutes.
In conclusion, repair of ascending and arch aneurysms
can be done with an acceptable mortality rate (especially
with elective surgery and normal GFR) and morbidity
(stroke rate). RCP was associated with a trend toward
a reduced incidence of hospital mortality and, in patients re-
ceiving prolonged hypothermic circulatory arrest, a reduced
incidence of stroke.A
C
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